The DEFINITE trial (Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation) [ 46 ] compared the benefit of ICD vs standard therapy in patients with HF (EF ≤ 35%) and premature ventricular contractions or NSVT, showing a strong trend toward reducing mortality with ICD.
← all excerpts
Inter-American Society of Cardiology (CIFACAH-ELECTROSIAC) and Latin-American Heart Rhythm Society (LAHRS): multidisciplinary review on the appropriate use of implantable cardiodefibrillator in heart failure with reduced ejection fraction.
1
—
—